Moneycontrol PRO
LAMF
LAMF

Medical Devices

Jump to
  • Zydus Lifesciences: Time to accumulate the stock?

    Tariffs pose a near-term risk. However, Zydus’s focus on novel drugs and the foray into medical devices are key moves to watch

  • Jashvik Capital and Futura Surgicare to jointly build products for medical industry

    The Indian medical devices opportunity is large and growing – roughly $11.25 billion of domestic demand and $3 billion of global demand that can be serviced from India

  • Race for Apax Partners promoted Healthium Medtech: KKR seen as lead contender

    In 2018, British private equity firm Apax Partners acquired Healthium Medtech from investors including TPG Growth and CX Partners

  • Wipro GE Healthcare to invest Rs 8,000 crore in 5 years on medical devices manufacturing, local R&D

    The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries.

  • AM Naik, Madhusudan Kela invest in medical devices company S3V Vascular Technologies

    The company will use the funds to build a Rs 300-crore integrated manufacturing facility for neurovascular devices at Mysore. 

  • India, US to increase engagement to address issues in medical devices trade

    The issue came up for discussion during the 14th Trade Policy Forum (TPF) meeting here. It was co-chaired by US Trade Representative Katherine Tai and Commerce and Industry Minister Piyush Goyal here.

  • L&T Tech Services collaborates with NVIDIA to reveal advanced architecture for medical devices

    The partnership makes use of the NVIDIA Holoscan and NVIDIA IGX Orin platforms, which have ultra-low latency in data transport, improved image processing, and scalability to support a variety of AI-enabled applications

  • India could become a medical devices powerhouse

    The Indian medical device industry is at an inflection point and the current policy could trigger the next phase of its growth

  • Delhi HC upholds Centre's decision to include all medical devices as drugs

    The court said the decision to include all medical devices as “drugs” was a policy matter and no case for interference was made out as there was no arbitrariness or unreasonableness.

  • Medical devices makers body AiMed asks govt to withdraw order on import of used medical devices

    Through a notification issued on June 19 this year, the government decided to allow the import of "high-end and high-value” used medical equipment other than critical care medical equipment, AiMeD stated.

  • Omron to open first Indian medical devices plant in Tamil Nadu: Report

  • Medical device policy: A boost for industry, while consumers can hope for affordable, high-quality products

  • PM Modi hails Cabinet decisions approving medical devices policy, setting up 157 govt nursing colleges

  • National Medical Devices Policy 2023 secures the Cabinet green light

  • Budget 2023: Medical device makers seek GST cut to battle imports from China, US

  • Parliamentary panel recommends regulators at different levels for medical devices industry

  • MC Explains | What does the Drugs, Medical Devices and Cosmetics Bill seek to achieve?

  • Technology has huge role in India’s healthcare, we aim to fill existing gaps: Siraj Dhanani, CEO, InnAccel

  • Decoding PLI: Tonic for manufacturing medical devices not strong enough

  • Big hospital chains face CCI scrutiny over inflated prices of medicines and medical devices

  • Zoho invests Rs 35 crore in medical devices startup Voxelgrids

  • COVID-19: Six US planes carrying medical supplies reached India in past few days

  • Social media as ‘Godsend’: In India, cries for help get results

  • PLI schemes for bulk drugs, medical devices received positive response from industry: Centre

  • Government's medical devices move: Industry expresses concern over compliance costs

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347